Nicholas DeVito, Assistant Professor of Medicine at the Division of Medical Oncology at Duke University, shared a post by JAMA Network Open on LinkedIn, adding:
“Research is drastically underfunded for gastrointestinal malignancies in a time of rising early onset rates of colorectal, pancreatic, and stomach cancer.
I may be biased, but ideally our response to this would be to have a dedicated federal initiative to address these diseases, providing funds in addition to the NIH’s current budget, that comprehensively support research spanning from prevention and screening to the basic/translational science that leads to better treatment outcomes (inclusive of investigator initiated trials).”
Quoting JAMA Network Open‘s post:
“US NIH cancer research funding per death is substantially higher for less-lethal cancers such as Breast Cancer and Prostate Cancer vs highly lethal cancers such as Small Cell Lung Cancer and Pancreatic Cancer.”
Title: Incidence, Mortality, and Federal Research Funding by Cancer Type in the US
Authors: Chirayu Mohindroo, Anish Thomas
Other articles featuring Nicholas DeVito on OncoDaily.
